Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Pharm Res ; 31(7): 1867-76, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24643933

RESUMEN

Biorelevant in vitro performance testing of orally administered dosage forms has become an important tool for the assessment of drug product in vivo behavior. An in vitro performance test which mimics the intraluminal performance of an oral dosage form is termed biorelevant. Biorelevant tests have been utilized to decrease the number of in vivo studies required during the drug development process and to mitigate the risk related to in vivo bioequivalence studies. This report reviews the ability of current in vitro performance tests to predict in vivo performance and generate successful in vitro and in vivo correlations for oral dosage forms. It also summarizes efforts to improve the predictability of biorelevant tests. The report is based on the presentations at the 2013 workshop, Biorelevant In Vitro Performance Testing of Orally Administered Dosage Forms, in Washington, DC, sponsored by the FIP Dissolution/Drug Release Focus Group in partnership with the American Association of Pharmaceutical Scientists (AAPS) and a symposium at the AAPS 2012 Annual meeting on the same topic.


Asunto(s)
Química Farmacéutica/educación , Química Farmacéutica/métodos , Evaluación Preclínica de Medicamentos/métodos , Preparaciones Farmacéuticas/administración & dosificación , Administración Oral , Química Farmacéutica/normas , Preparaciones de Acción Retardada/química , Preparaciones de Acción Retardada/metabolismo , Formas de Dosificación , Evaluación Preclínica de Medicamentos/normas , Humanos , Farmacocinética , Control de Calidad , Solubilidad
2.
Pharm Res ; 27(5): 750-5, 2010 May.
Artículo en Inglés | MEDLINE | ID: mdl-20217462

RESUMEN

The major metals of potential health concern found in food, drugs (medicines), and dietary supplements are lead, cadmium, mercury, and arsenic. Other metals, such as chromium, copper, manganese, molybdenum, vanadium, nickel, osmium, rhodium, ruthenium, iridium, palladium, and platinum, may be used or introduced during manufacturing and may be controlled in the final article as impurities. Screening for metals in medicines and dietary supplements rarely indicates the presence of toxic metal impurities at levels of concern. The setting of heavy metal limits is appropriate for medicines and is appropriate for supplements when heavy metals are likely or certain to contaminate a given product. Setting reasonable health-based limits for some of these metals is challenging because of their ubiquity in the environment, limitations of current analytical procedures, and other factors. Taken together, compendial tests for metals in food and drugs present an array of issues that challenge compendial scientists.


Asunto(s)
Contaminación de Medicamentos , Contaminación de Alimentos/análisis , Metales/análisis , Animales , Química Farmacéutica , Análisis de los Alimentos , Humanos , Metales/toxicidad , Farmacopeas como Asunto , Valores Limites del Umbral
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA